Also affiliated with Japanese Foundation For Cancer Research
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Driven by 4 papers. Top paper: “Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study”.
Philippe A. Cassier, Marwan Fakih, Steven Kao, Dorte Nielsen, Antoîne Italiano +17 more
Yukiko Sato, Reimi Asaka, Naoki Fukuda, Xiaofei Wang, Tetsuya Urasaki +12 more
Yoshinori Ito, Akeshi Morimatsu, Masatoshi Jinnin, Keiichiro Tada, Naoki Sakurai +6 more
Hiroji Iwata, Ian E. Krop, Pasi A. Jänne, Toshihiko Doi, Shunji Takahashi +11 more